ASCO 2020 – Focus on Lung Cancer

Expert perspectives and strategic insights on the latest therapeutic developments and translational research in lung cancer treatment.

Corey Langer MD Scientific Leader Faculty Chair Aptitude Health

Faculty Chair

Corey Langer, MD, FACP

University of Pennsylvania, US

Key Takeaways and Strategic Insights

  • Immunotherapy: Stage IV NSCLC and Biomarker Research
  • Immunotherapy and Targeted Agents in Stage I–III NSCLC
  • Targeting Gene Fusions (ALK, RET, NTRK)
  • Targeting Gene Mutations, Insertions, Amplifications (EGFR, MET, HER2, KRAS)
  • New Approaches in Non-Small Cell Lung Cancer
  • New Approaches in Small Cell Lung Cancer

Faculty Members

Solange Peters, MD, PhD
Lausanne University Hospital, Lausanne, Switzerland

Nasser Hanna, MD
Indiana University School of Medicine, Indianapolis, IN, US

Jyoti Patel, MD, FASCO
Northwestern University Feinberg School of Medicine, Evanston, IL, US

David Spigel, MD
Sarah Cannon Research Institute Nashville, TN, US

Enriqueta Felip, MD, PhD
Vall d’Hebron University Hospital, Barcelona, Spain

Julie Brahmer, MD
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, US

Explore Available and Upcoming Insight Reports

View Reports